bisindolylmaleimide iv and cgp 53353

bisindolylmaleimide iv has been researched along with cgp 53353 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buchdunger, E; Furet, P; Kump, W; Lydon, N; Mett, H; Meyer, T; Müller, M; Regenass, U; Rihs, G; Trinks, U	1
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A	1

Other Studies

2 other study(ies) available for bisindolylmaleimide iv and cgp 53353

Article	Year
Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase. Journal of medicinal chemistry, 1994, Apr-01, Volume: 37, Issue:7 Topics: 3T3 Cells; Adenosine Triphosphate; Animals; Antineoplastic Agents; Binding, Competitive; Cells, Cultured; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Humans; Mice; Mice, Inbred BALB C; Phosphorylation; Phthalimides; Proto-Oncogene Proteins c-fos; RNA, Messenger; Structure-Activity Relationship; Tumor Cells, Cultured; Tyrosine	1994
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2 Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase	2013

Article

Year

Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase.

Journal of medicinal chemistry, 1994, Apr-01, Volume: 37, Issue:7

Topics: 3T3 Cells; Adenosine Triphosphate; Animals; Antineoplastic Agents; Binding, Competitive; Cells, Cultured; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Humans; Mice; Mice, Inbred BALB C; Phosphorylation; Phthalimides; Proto-Oncogene Proteins c-fos; RNA, Messenger; Structure-Activity Relationship; Tumor Cells, Cultured; Tyrosine

1994

A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.

The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2

Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase

2013